Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?

E. Jensen-Jarolim*, J. Singer

*Corresponding author for this work

Research output: Journal article (peer-reviewed)Editorial

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)1337-1340
Number of pages4
JournalClinical and Experimental Allergy
Issue number10
Publication statusPublished - Oct 2011
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this